Green Plains Reports First Quarter 2020 Financial Results
Results for the First Quarter of 2020:Net loss attributable to the company of $16.4 million, or $(0.47) per diluted share […]
PDS Biotechnology Announces Conference Call and Webcast for First Quarter 2020 Financial Results
FLORHAM PARK, N.J., May 04, 2020 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel […]
Capitala Finance Corp. Receives “Green Light” from Small Business Administration for Fifth SBIC License
CHARLOTTE, N.C., May 04, 2020 (GLOBE NEWSWIRE) — Capitala Group (“Capitala”), a leading provider of capital to lower middle market […]
Bellerophon Therapeutics to Participate in COVID-19 Panel at Maxim Group’s Infectious Disease Virtual Conference
WARREN, N.J., May 04, 2020 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. (Nasdaq: BLPH), a clinical-stage biotherapeutics company focused on developing […]
HF Foods Appoints Victor Lee as Chief Financial Officer
CITY OF INDUSTRY, Calif., May 04, 2020 (GLOBE NEWSWIRE) — HF Foods Group Inc. (NASDAQ: HFFG), a leading food distributor […]
ChemoCentryx to Hold First Quarter 2020 Financial Results Conference Call on Monday, May 11, 2020
MOUNTAIN VIEW, Calif., May 04, 2020 (GLOBE NEWSWIRE) — ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the Company’s first quarter […]
IZEA Announces “BrandGraph® for COVID-19 Competitive Intelligence” Streaming Event
Orlando, Florida, May 04, 2020 (GLOBE NEWSWIRE) — IZEA Worldwide, Inc. (NASDAQ: IZEA), operator of IZEAx®, the premier online marketplace connecting […]
Corbus Pharmaceuticals to Report First Quarter Results on May 11, 2020
– Management to host conference call and webcast on Monday, May 11 at 8:30 a.m. ET-NORWOOD, MA, May 04, 2020 […]
Catalyst Pharmaceuticals to Hold First Quarter 2020 Financial Results and Corporate Update Conference Call and Webcast on Tuesday, May 12th, 2020
CORAL GABLES, Fla., May 04, 2020 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused […]
Seelos Therapeutics Receives Notice of Allowance for an Additional US Patent for Trehalose (SLS-005)
NEW YORK, May 04, 2020 (GLOBE NEWSWIRE) — Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the […]
